Morning Market Losers

Kindred Biosciences KIN shares slipped 31.41% to $6.34 after the company reported that it has decided to stop its Atokin study. Aéropostale ARO shares fell 19.12% to $2.58 after the company issued a weak forecast for the fourth quarter. The company expected a loss of $0.37 to $0.44 per share, versus analysts' expectations for a $0.37 per share loss. The company also announced its plans to close around 75 stores in the current quarter. However, the company reported upbeat revenue for the third quarter. Christopher & Banks CBK tumbled 18.78% to $5.58 after the company reported weaker-than-expected sales for the third quarter and issued a downbeat forecast for the fourth quarter. However, the company posted upbeat quarterly earnings. Gildan Activewear GIL shares fell 13.01% to $50.69 after the company reported a weaker-than-expected profit for the fourth quarter and issued a weak guidance. Barnes & Noble BKS dipped 11.58% to $19.67 after the company reported weaker-than-expected fiscal second-quarter profit. The company also announced that it is ending its commercial deal with Microsoft MSFT. UTi Worldwide UTIW shares dropped 11.53% to $12.28. During Wednesday's trade, shares of UTi surged following a report that DSV A/S was interested in buying the company. After hours Wednesday, UTi Worldwide there are currently no discussions between the two companies. ANI Pharmaceuticals ANIP shares fell 11.10% to $53.53 after the company announced a $100 million public offering of convertible notes. Express EXPR shares declined 10.90% to $12.91 after the company cut its forecast for the year. SeaChange International SEAC shares dropped 8.70% to $6.40 after the company reported a Q3 loss of $0.07 per share on revenue of $30.0 million and lowered its FY15 outlook.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsmarket losersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!